Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences

Provided By GlobeNewswire

Last update: Jul 22, 2025

BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific conferences in July and August 2025.